Jakavi 5 mg Tabs image 1
01 / 04

Genuine Medicines

Tracked Shipping

Plain Packaging

Order Metadata
ReferenceGH·JAKAVI50
AvailabilityIn stock
SourceIndia
Delivery5–10 business days to your country
GH·JAKAVI50Pharmaceutical Tablets (Misc)

Jakavi 5 mg Tabs

Ruxolitinib is a prescription medicine used to treat myelofibrosis, a bone marrow disorder that causes an enlarged spleen and tiredness, and polycythemia vera, in which the body makes too many red blood cells. It is also used for graft-versus-host disease after a stem cell transplant. It works by blocking JAK proteins that drive abnormal blood cell growth and inflammation. It is taken by mouth twice daily and only under the supervision of a specialist doctor.

Order This Product

Send us a message on WhatsApp with this product name — we'll come back with the price and delivery options for your country.

Description

Ruxolitinib belongs to a group called Janus kinase (JAK) inhibitors, which block JAK1 and JAK2 signals that are overactive in many bone marrow disorders. This reduces spleen size, relieves symptoms such as night sweats, itching, bone pain, and weight loss, and improves quality of life. It is prescribed for intermediate and high-risk myelofibrosis, for polycythemia vera in people who have not responded to or cannot take hydroxyurea, and for acute and chronic graft-versus-host disease in adults and some children. The starting dose depends on the platelet count, and it is taken twice daily, with or without food, at about the same times each day. Blood counts are checked before and regularly during treatment, because low platelets and low red blood cells are common, and the dose is adjusted, paused, or reduced accordingly. Other common side effects include bruising, dizziness, headache, weight gain, high cholesterol, raised liver enzymes, and urinary tract infections. Because it weakens the immune system, it can raise the risk of serious infections, including tuberculosis, shingles, and hepatitis B reactivation, so screening is done before starting. Fever, chills, or signs of infection need urgent medical attention. It carries warnings for major heart problems, blood clots, and certain cancers, especially in people over 50 or with heart disease risk factors, and non-melanoma skin cancer checks are advised. Strong CYP3A4 inhibitors such as ketoconazole and clarithromycin, and fluconazole at high doses, can raise its levels, and the dose is reduced, while inducers such as rifampicin can lower them. The dose must also be reduced in people with kidney or liver problems. Stopping it suddenly can cause a return of symptoms, sometimes with a rapid spleen enlargement, so it should be tapered under medical guidance. It should be avoided in pregnancy and breastfeeding, and women are advised to use effective contraception during treatment and for a short period afterward. The dose should never be changed or stopped without the specialist’s advice.

Specifications

Composition
Ruxolitinib
Strength
5 mg
Treatment
Blood Disorder Medicine
Packaging Type
Strips
Packaging Size
1 x 10 Tablets

How this product reaches you

  1. 1Global Healthcare sources this product from a manufacturer in India. The manufacturer name and country are part of the order record.
  2. 2It is shipped from India to your address. Carrier and delivery options depend on your country and order size.
  3. 3Your country's import rules apply — we help you understand them on chat.

Similar Products